首页 > 最新文献

BMJ Innovations最新文献

英文 中文
Development and testing of an intact cord resuscitation trolley 完整脐带复苏小车的研制与试验
IF 2 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2022-06-22 DOI: 10.1136/bmjinnov-2022-000950
Jaspreet Singh Raina, Deepak Chawla, Suksham Jain, S. Khurana
Objective To develop a mobile resuscitation platform—intact cord resuscitation (ICR) trolley and to assess the safety, feasibility and acceptability of its use during delayed cord clamping (DCC). Study design Bench-side product development and single-arm experimental study. Participants and methods We first developed a theoretical framework of the specifications required for the platform which can provide resuscitation close to the delivery/operating table. The theoretical framework was then translated into a working model in a series of iterations. After testing and training of healthcare workers in a simulated environment, the trolley was tested to perform DCC in neonates who were born at ≥34 weeks of gestation and were breathing spontaneously at birth. Outcomes measured Primary outcome was the feasibility of DCC using the ICR trolley defined as the proportion of babies successfully completing 180 s of DCC on the trolley. Secondary outcomes included the proportion of babies with 1 min heart rate (HR) and oxygen saturation (SpO2) recorded, neonatal and maternal safety outcomes, and acceptability among care providers. Results Among 50 neonates (gestation: 36.9±1.9 weeks and birth weight: 2544±649 g) enrolled in the study, DCC for ≥180 s was successfully done in 42 (84%) neonates. The mean duration of DCC was 170±27 s. HR and SpO2 at 1 min were recorded successfully in 92% of the babies. The majority of the maternal and neonatal care provider strongly supported the use of ICR trolley. Conclusion We developed an ICR trolley and successfully tested the feasibility and acceptability of its use in healthy neonates undergoing DCC.
目的研制一种移动式复苏平台——完整脐带复苏台车,并评价其在延迟脐带夹持(DCC)中应用的安全性、可行性和可接受性。研究设计:台架产品开发及单臂实验研究。参与者和方法我们首先开发了平台所需规格的理论框架,该平台可以在分娩/手术台上提供复苏。在一系列的迭代中,理论框架被转化为一个工作模型。在模拟环境中对医护人员进行测试和培训后,对妊娠≥34周出生且出生时自主呼吸的新生儿进行DCC测试。主要结果是使用ICR手推车进行DCC的可行性,定义为婴儿在手推车上成功完成180 s DCC的比例。次要结局包括记录1分钟心率(HR)和血氧饱和度(SpO2)的婴儿比例、新生儿和产妇安全结局以及护理提供者的可接受性。结果纳入研究的50例新生儿(妊娠期36.9±1.9周,出生体重2544±649 g)中,42例(84%)成功行DCC≥180 s。DCC的平均持续时间为170±27 s。92%的婴儿成功记录了1分钟时的HR和SpO2。大多数孕产妇和新生儿护理提供者强烈支持使用ICR手推车。结论研制了ICR小车,并成功验证了其在健康新生儿DCC中应用的可行性和可接受性。
{"title":"Development and testing of an intact cord resuscitation trolley","authors":"Jaspreet Singh Raina, Deepak Chawla, Suksham Jain, S. Khurana","doi":"10.1136/bmjinnov-2022-000950","DOIUrl":"https://doi.org/10.1136/bmjinnov-2022-000950","url":null,"abstract":"Objective To develop a mobile resuscitation platform—intact cord resuscitation (ICR) trolley and to assess the safety, feasibility and acceptability of its use during delayed cord clamping (DCC). Study design Bench-side product development and single-arm experimental study. Participants and methods We first developed a theoretical framework of the specifications required for the platform which can provide resuscitation close to the delivery/operating table. The theoretical framework was then translated into a working model in a series of iterations. After testing and training of healthcare workers in a simulated environment, the trolley was tested to perform DCC in neonates who were born at ≥34 weeks of gestation and were breathing spontaneously at birth. Outcomes measured Primary outcome was the feasibility of DCC using the ICR trolley defined as the proportion of babies successfully completing 180 s of DCC on the trolley. Secondary outcomes included the proportion of babies with 1 min heart rate (HR) and oxygen saturation (SpO2) recorded, neonatal and maternal safety outcomes, and acceptability among care providers. Results Among 50 neonates (gestation: 36.9±1.9 weeks and birth weight: 2544±649 g) enrolled in the study, DCC for ≥180 s was successfully done in 42 (84%) neonates. The mean duration of DCC was 170±27 s. HR and SpO2 at 1 min were recorded successfully in 92% of the babies. The majority of the maternal and neonatal care provider strongly supported the use of ICR trolley. Conclusion We developed an ICR trolley and successfully tested the feasibility and acceptability of its use in healthy neonates undergoing DCC.","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":"1 1","pages":"323 - 328"},"PeriodicalIF":2.0,"publicationDate":"2022-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83235940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Design and development of a clinical decision support system for community health workers to support early detection and management of non-communicable disease 为社区卫生工作者设计和开发临床决策支持系统,以支持非传染性疾病的早期发现和管理
IF 2 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2022-06-16 DOI: 10.1136/bmjinnov-2022-000952
S. Zaman, Nisal De Silva, Tian Yu Goh, R. Evans, Rajkumari Singh, Rajesh Singh, Ashutosh Kumar Singh, P. Singh, A. Thrift
Background Numerous groups have developed software applications (apps) for use by community health workers (CHWs) in hard-to-reach settings. However, these have either not been based on clinical guidelines or are not freely available. Our objectives were to (1) design and develop an app for use by CHWs; and (2) conduct preliminary testing of the app to identify potential obstacles. Methods We used the principle of human-centred design to develop an app programmed to an Android operating system. We used a mixed-methods approach which included site observations, meetings with stakeholders and the app development team, and laboratory simulation to fine tune the design. The ‘Mobile Application Rating Scale’ (MARS) was used for testing reliability and quality. We also assessed the validity of the app by matching the uploaded data with ‘gold standard’ preset answers. Results Depending on human–computer interactions, the app has reminder, advisor, critic and guide functions which can facilitate CHWs to make clinical decisions. We found the app is usable based on the final score of the MARS tool, and that the entered data were accurate. We present the simple procedures that were followed to develop this Android app. The app, including all of its code, is freely available. Conclusion The app shows promise as a tool for the management of non-communicable disease in a rural setting in India. The next step will be to refine the app in a field setting and then to evaluate its efficacy in a large-scale clinical trial.
背景:许多团体开发了软件应用程序,供社区卫生工作者在难以到达的环境中使用。然而,这些要么不是基于临床指南,要么不是免费提供的。我们的目标是:(1)设计和开发一个应用程序供卫生工作者使用;(2)对应用程序进行初步测试,识别潜在的障碍。方法采用以人为本的设计原则,开发Android操作系统应用程序。我们使用了混合方法,包括现场观察,与利益相关者和应用开发团队的会议,以及实验室模拟来微调设计。“移动应用评级量表”(MARS)用于测试可靠性和质量。我们还通过将上传的数据与“黄金标准”预设答案进行匹配来评估应用程序的有效性。结果应用程序通过人机交互,具有提示、咨询、批评、指导等功能,可方便卫生工作者进行临床决策。根据火星工具的最终得分,我们发现这款应用是可用的,输入的数据是准确的。我们介绍了开发这个Android应用程序所遵循的简单过程。该应用程序包括其所有代码都是免费提供的。这款应用有望成为印度农村地区管理非传染性疾病的工具。下一步将是在实地环境中完善应用程序,然后在大规模临床试验中评估其功效。
{"title":"Design and development of a clinical decision support system for community health workers to support early detection and management of non-communicable disease","authors":"S. Zaman, Nisal De Silva, Tian Yu Goh, R. Evans, Rajkumari Singh, Rajesh Singh, Ashutosh Kumar Singh, P. Singh, A. Thrift","doi":"10.1136/bmjinnov-2022-000952","DOIUrl":"https://doi.org/10.1136/bmjinnov-2022-000952","url":null,"abstract":"Background Numerous groups have developed software applications (apps) for use by community health workers (CHWs) in hard-to-reach settings. However, these have either not been based on clinical guidelines or are not freely available. Our objectives were to (1) design and develop an app for use by CHWs; and (2) conduct preliminary testing of the app to identify potential obstacles. Methods We used the principle of human-centred design to develop an app programmed to an Android operating system. We used a mixed-methods approach which included site observations, meetings with stakeholders and the app development team, and laboratory simulation to fine tune the design. The ‘Mobile Application Rating Scale’ (MARS) was used for testing reliability and quality. We also assessed the validity of the app by matching the uploaded data with ‘gold standard’ preset answers. Results Depending on human–computer interactions, the app has reminder, advisor, critic and guide functions which can facilitate CHWs to make clinical decisions. We found the app is usable based on the final score of the MARS tool, and that the entered data were accurate. We present the simple procedures that were followed to develop this Android app. The app, including all of its code, is freely available. Conclusion The app shows promise as a tool for the management of non-communicable disease in a rural setting in India. The next step will be to refine the app in a field setting and then to evaluate its efficacy in a large-scale clinical trial.","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":"6 1","pages":"49 - 56"},"PeriodicalIF":2.0,"publicationDate":"2022-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81701306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
National Institutes of Health Stroke Scale scores obtained using a mobile application compared to the conventional paper form: a randomised controlled validation study 使用移动应用程序获得的美国国立卫生研究院卒中量表分数与传统纸质表格的比较:一项随机对照验证研究
IF 2 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2022-06-16 DOI: 10.1136/bmjinnov-2022-000968
H. Bugge, M. Guterud, J. Røislien, K. Larsen, H. Ihle-Hansen, M. Toft, M. R. Hov, E. Sandset
Background Prehospital delay contributes to treatment delay in acute stroke. Numerous prehospital stroke scales exist for stroke identification, but they lack the diagnostic accuracy of the in-hospital National Institutes of Health Stroke Scale (NIHSS). We have developed a mobile application to aid paramedics assessing prehospital NIHSS. This study explores agreement between NIHSS scores obtained using the Paramedic Norwegian Acute Stroke Prehospital Project (ParaNASPP) application compared with conventional assessment. Methods 25 physicians working with stroke were randomised to an application group or control. 20 unique videos portraying acute stroke symptoms were scored by both groups. 95% limits of agreement (LoA) were calculated using Bland-Altman’s method, comparing the groups to predefined scores, and each other. LoAs within ±3 NIHSS points were considered acceptable. Cohen’s kappa was calculated on dichotomised NIHSS scores. Results The ParaNASPP application group had 95% LoA of −2.33 to 2.71. The control group had LoA of −2.60 to 2.55. Direct comparison between the groups gave LoA of −3.12 to 3.55. When compared with the dichotomised predefined scores kappa was 0.93 in the application group and 0.89 in the control group. Kappa was 0.84 for direct comparison between the groups. Discussion There was very good agreement between the application and both the predefined score and the control group. Scores from the ParaNASPP application differ slightly more than our predefined goal when compared with the control group, but is well within when compared with the predefined NIHSS scores. We consider this acceptable and the ParaNASPP application validated for further clinical studies.
院前延迟导致急性脑卒中治疗延迟。许多院前卒中量表用于卒中识别,但它们缺乏院内国立卫生研究院卒中量表(NIHSS)的诊断准确性。我们开发了一个移动应用程序来帮助护理人员评估院前NIHSS。本研究探讨了使用护理人员挪威急性卒中院前项目(ParaNASPP)应用程序获得的NIHSS评分与传统评估之间的一致性。方法将25名治疗脑卒中的医生随机分为应用组和对照组。两组分别对20个描述急性中风症状的独特视频进行评分。使用Bland-Altman方法计算95%的一致限度(LoA),将各组与预定义分数进行比较,并相互比较。在±3 NIHSS点以内的LoAs被认为是可以接受的。Cohen的kappa是根据NIHSS的二分分数计算的。结果应用ParaNASPP组95% LoA为- 2.33 ~ 2.71。对照组的LoA为−2.60 ~ 2.55。组间直接比较LoA为- 3.12 ~ 3.55。与二分类的预定义分数相比,应用组的kappa为0.93,对照组为0.89。组间直接比较Kappa为0.84。应用程序与预定义分数和对照组之间的一致性非常好。与对照组相比,ParaNASPP应用程序的分数与我们预定的目标略有不同,但与预定的NIHSS分数相比,相差不大。我们认为这是可以接受的,并且ParaNASPP的应用验证了进一步的临床研究。
{"title":"National Institutes of Health Stroke Scale scores obtained using a mobile application compared to the conventional paper form: a randomised controlled validation study","authors":"H. Bugge, M. Guterud, J. Røislien, K. Larsen, H. Ihle-Hansen, M. Toft, M. R. Hov, E. Sandset","doi":"10.1136/bmjinnov-2022-000968","DOIUrl":"https://doi.org/10.1136/bmjinnov-2022-000968","url":null,"abstract":"Background Prehospital delay contributes to treatment delay in acute stroke. Numerous prehospital stroke scales exist for stroke identification, but they lack the diagnostic accuracy of the in-hospital National Institutes of Health Stroke Scale (NIHSS). We have developed a mobile application to aid paramedics assessing prehospital NIHSS. This study explores agreement between NIHSS scores obtained using the Paramedic Norwegian Acute Stroke Prehospital Project (ParaNASPP) application compared with conventional assessment. Methods 25 physicians working with stroke were randomised to an application group or control. 20 unique videos portraying acute stroke symptoms were scored by both groups. 95% limits of agreement (LoA) were calculated using Bland-Altman’s method, comparing the groups to predefined scores, and each other. LoAs within ±3 NIHSS points were considered acceptable. Cohen’s kappa was calculated on dichotomised NIHSS scores. Results The ParaNASPP application group had 95% LoA of −2.33 to 2.71. The control group had LoA of −2.60 to 2.55. Direct comparison between the groups gave LoA of −3.12 to 3.55. When compared with the dichotomised predefined scores kappa was 0.93 in the application group and 0.89 in the control group. Kappa was 0.84 for direct comparison between the groups. Discussion There was very good agreement between the application and both the predefined score and the control group. Scores from the ParaNASPP application differ slightly more than our predefined goal when compared with the control group, but is well within when compared with the predefined NIHSS scores. We consider this acceptable and the ParaNASPP application validated for further clinical studies.","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":"41 1","pages":"57 - 63"},"PeriodicalIF":2.0,"publicationDate":"2022-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86903358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Social innovation in health, community engagement, financing and outcomes: qualitative analysis from the social innovation in health initiative 卫生方面的社会创新、社区参与、筹资和成果:来自卫生方面的社会创新倡议的定性分析
IF 2 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2022-06-10 DOI: 10.1136/bmjinnov-2021-000902
Patricia Moscibrodzki, Emmanuel Ahumuza, Jingjing Li, Xiaoming Sun, Yusha Tao, L. van Niekerk, U. Amazigo, B. Halpaap, P. Awor, Joseph D. Tucker
Background Social innovation in health is a community-engaged process that links social change and health improvement, drawing on the diverse strengths of local individuals and institutions. However, there are few studies that examine community engagement, financing and outcomes. The purpose of this study is to use a qualitative descriptive analysis to assess 40 social innovations in health identified through a global open call. Methods This qualitative analysis examined social innovation case studies from low- and middle-income countries identified by a global social innovation network. A crowdsourcing open call identified projects and key components of each social innovation were evaluated by an independent panel. We used a US Centers for Disease Control and Prevention framework to measure community engagement as shared leadership, collaboration, involvement, consultation or informing. We used descriptive statistics to examine key aspects of community engagement, financing, health outcomes and non-health outcomes. Results Data from 40 social innovations were examined. Social innovations were from Africa (21/40), Asia (11/40), and Latin America and the Caribbean (8/40). Community engagement was diverse and robust across the cases and 60% (24/40) had either shared leadership or collaboration. Financing for social innovation came from research grants (23), national or provincial government support (15), revenues from sales (13), donations (13) and local government support (10). Social innovations reported health and non-health outcomes. Conclusion Our data demonstrate social innovations had robust community engagement. Innovative financing mechanisms provide mechanisms for sustaining social innovations. Further research on health and non-health outcomes of social innovation is needed.
卫生领域的社会创新是一个社区参与的进程,利用当地个人和机构的各种优势,将社会变革和健康改善联系起来。然而,很少有研究考察社区参与、融资和结果。本研究的目的是使用定性描述性分析来评估通过全球公开呼吁确定的40项卫生社会创新。方法通过全球社会创新网络对中低收入国家的社会创新案例进行定性分析。众包公开征集确定了每个社会创新的项目和关键组成部分,并由一个独立小组进行评估。我们使用美国疾病控制和预防中心的框架来衡量社区参与,包括共同领导、合作、参与、咨询或通报。我们使用描述性统计来检查社区参与、融资、健康结果和非健康结果的关键方面。结果对40项社会创新的数据进行了分析。社会创新来自非洲(21/40)、亚洲(11/40)和拉丁美洲和加勒比(8/40)。在所有案例中,社区参与是多样化和强有力的,60%(24/40)的案例要么是共同领导,要么是合作。社会创新的资金来源包括研究经费(23项)、国家或省政府支持(15项)、销售收入(13项)、捐赠(13项)和地方政府支持(10项)。社会创新报告了健康和非健康结果。我们的数据表明,社会创新具有强大的社区参与。创新融资机制为持续社会创新提供了机制。需要进一步研究社会创新的健康和非健康结果。
{"title":"Social innovation in health, community engagement, financing and outcomes: qualitative analysis from the social innovation in health initiative","authors":"Patricia Moscibrodzki, Emmanuel Ahumuza, Jingjing Li, Xiaoming Sun, Yusha Tao, L. van Niekerk, U. Amazigo, B. Halpaap, P. Awor, Joseph D. Tucker","doi":"10.1136/bmjinnov-2021-000902","DOIUrl":"https://doi.org/10.1136/bmjinnov-2021-000902","url":null,"abstract":"Background Social innovation in health is a community-engaged process that links social change and health improvement, drawing on the diverse strengths of local individuals and institutions. However, there are few studies that examine community engagement, financing and outcomes. The purpose of this study is to use a qualitative descriptive analysis to assess 40 social innovations in health identified through a global open call. Methods This qualitative analysis examined social innovation case studies from low- and middle-income countries identified by a global social innovation network. A crowdsourcing open call identified projects and key components of each social innovation were evaluated by an independent panel. We used a US Centers for Disease Control and Prevention framework to measure community engagement as shared leadership, collaboration, involvement, consultation or informing. We used descriptive statistics to examine key aspects of community engagement, financing, health outcomes and non-health outcomes. Results Data from 40 social innovations were examined. Social innovations were from Africa (21/40), Asia (11/40), and Latin America and the Caribbean (8/40). Community engagement was diverse and robust across the cases and 60% (24/40) had either shared leadership or collaboration. Financing for social innovation came from research grants (23), national or provincial government support (15), revenues from sales (13), donations (13) and local government support (10). Social innovations reported health and non-health outcomes. Conclusion Our data demonstrate social innovations had robust community engagement. Innovative financing mechanisms provide mechanisms for sustaining social innovations. Further research on health and non-health outcomes of social innovation is needed.","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":"125 1","pages":"216 - 223"},"PeriodicalIF":2.0,"publicationDate":"2022-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80435752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Structured digital care pathway for systemic acne treatment using isotretinoin 结构化的数字护理途径,系统性痤疮治疗使用异维甲酸
IF 2 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2022-06-08 DOI: 10.1136/bmjinnov-2021-000917
Amandip Sangha, M. Rizvi
© Author(s) (or their employer(s)) 2022. No commercial reuse. See rights and permissions. Published by BMJ. INTRODUCTION Acne is a condition that affects a large portion of the population, especially younger people. The condition is well documented as being a formidable burden on the patient, psychologically and socially. Moreover, the severe forms of acne can leave permanent scars on the skin, if not properly treated. Treatments of acne consist of a range of various topical treatments sometimes combined with antibiotics administered orally. Among the most potent systemic treatment options, there is isotretinoin, which is a vitamin Aderivative. In treating acne, isotretinoin works by ► Reducing sebum production. ► Shrinking the sebaceous glands. ► Reducing follicular occlusion. ► Inhibiting the growth of bacteria. ► Having antiinflammatory effects. Isotretinoin is administered orally in the form of capsules that are ingested daily over a longer period of time, typically over a course of 6–12 months. In most cases, the effect of the treatment is prolonged and sometimes permanent. The treatment of acne using isotretinoin includes regular followups and blood tests. Female patients need to be strongly advised against pregnancy due to the severe teratogenic effect. Among other known side effects are liver toxicity and elevated blood lipids. (Depression and other psychological problems are possible, although much debated side effects). 4 Hence, liver enzymes and lipid panels should be monitored. A safe treatment plan will include checkups with the doctor for blood work, patient– doctor conversation and guidance during the treatment. Though the frequency of blood tests need not be monthly for standard doses. In our service design research phase, we identified some key challenges that acne patients meet, when being considered for isotretinoin treatment. ► General practitioners (GPs) sometimes lack the knowledge of isotretinoin for acne treatment. It is a specialised task better left WHAT ARE THE NEW FINDINGS ⇒ Digital care pathway for treatment of acne using isotretinoin aims to streamline both patient and dermatologist user experience. ⇒ The digital service is built with care for medical soundness and treatment safety. ⇒ Communication between patient and doctor is facilitated through frequent message exchanges. ⇒ Knowledge transfer to patient is addressed. ⇒ The digital care pathway aims to make the treatment more accessible, and the digital experience more user friendly and efficient. ⇒ Provides a working example of a modern, teledermatological, digital care pathway for systemic treatment of acne using isotretinoin.
©作者(或其雇主)2022。禁止商业重用。请参阅权利和权限。英国医学杂志出版。痤疮是一种影响很大一部分人的疾病,尤其是年轻人。这种情况在心理上和社会上对患者来说都是一个巨大的负担。此外,如果治疗不当,严重的痤疮会在皮肤上留下永久的疤痕。痤疮的治疗包括一系列不同的局部治疗,有时与口服抗生素联合使用。在最有效的全身治疗方案中,有异维甲酸,这是一种维生素衍生物。在治疗痤疮时,异维甲酸通过减少皮脂的产生而起作用。►皮脂腺萎缩。►减少滤泡闭塞。►抑制细菌生长。►有抗炎作用。异维甲酸以胶囊形式口服,在较长时间内每天摄入,通常为6-12个月。在大多数情况下,治疗的效果是长期的,有时是永久性的。使用异维甲酸治疗痤疮包括定期随访和血液检查。由于严重的致畸作用,需要强烈建议女性患者不要怀孕。其他已知的副作用包括肝毒性和血脂升高。(抑郁症和其他心理问题是可能的,尽管有很多争论的副作用)。因此,应监测肝酶和脂质板。一个安全的治疗计划将包括与医生进行血液检查,患者与医生的对话和治疗期间的指导。虽然标准剂量的血液检查频率不需要每月一次。在我们的服务设计研究阶段,我们确定了痤疮患者在考虑异维甲酸治疗时遇到的一些关键挑战。►全科医生(gp)有时缺乏治疗痤疮的异维甲酸知识。使用异维甲酸治疗痤疮的数字护理途径旨在简化患者和皮肤科医生的用户体验。⇒数字服务的建立是为了医疗健康和治疗安全。通过频繁的信息交流,促进了病人和医生之间的沟通。⇒向患者传授知识。⇒数字护理途径旨在使治疗更容易获得,并使数字体验更方便用户和高效。⇒提供了一个使用异维甲酸对痤疮进行系统治疗的现代远程皮肤病学数字护理途径的工作实例。
{"title":"Structured digital care pathway for systemic acne treatment using isotretinoin","authors":"Amandip Sangha, M. Rizvi","doi":"10.1136/bmjinnov-2021-000917","DOIUrl":"https://doi.org/10.1136/bmjinnov-2021-000917","url":null,"abstract":"© Author(s) (or their employer(s)) 2022. No commercial reuse. See rights and permissions. Published by BMJ. INTRODUCTION Acne is a condition that affects a large portion of the population, especially younger people. The condition is well documented as being a formidable burden on the patient, psychologically and socially. Moreover, the severe forms of acne can leave permanent scars on the skin, if not properly treated. Treatments of acne consist of a range of various topical treatments sometimes combined with antibiotics administered orally. Among the most potent systemic treatment options, there is isotretinoin, which is a vitamin Aderivative. In treating acne, isotretinoin works by ► Reducing sebum production. ► Shrinking the sebaceous glands. ► Reducing follicular occlusion. ► Inhibiting the growth of bacteria. ► Having antiinflammatory effects. Isotretinoin is administered orally in the form of capsules that are ingested daily over a longer period of time, typically over a course of 6–12 months. In most cases, the effect of the treatment is prolonged and sometimes permanent. The treatment of acne using isotretinoin includes regular followups and blood tests. Female patients need to be strongly advised against pregnancy due to the severe teratogenic effect. Among other known side effects are liver toxicity and elevated blood lipids. (Depression and other psychological problems are possible, although much debated side effects). 4 Hence, liver enzymes and lipid panels should be monitored. A safe treatment plan will include checkups with the doctor for blood work, patient– doctor conversation and guidance during the treatment. Though the frequency of blood tests need not be monthly for standard doses. In our service design research phase, we identified some key challenges that acne patients meet, when being considered for isotretinoin treatment. ► General practitioners (GPs) sometimes lack the knowledge of isotretinoin for acne treatment. It is a specialised task better left WHAT ARE THE NEW FINDINGS ⇒ Digital care pathway for treatment of acne using isotretinoin aims to streamline both patient and dermatologist user experience. ⇒ The digital service is built with care for medical soundness and treatment safety. ⇒ Communication between patient and doctor is facilitated through frequent message exchanges. ⇒ Knowledge transfer to patient is addressed. ⇒ The digital care pathway aims to make the treatment more accessible, and the digital experience more user friendly and efficient. ⇒ Provides a working example of a modern, teledermatological, digital care pathway for systemic treatment of acne using isotretinoin.","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":"2 1","pages":"312 - 316"},"PeriodicalIF":2.0,"publicationDate":"2022-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83561494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of a real time ultrasound guided lumbar puncture device 实时超声引导腰椎穿刺装置的研制
IF 2 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2022-06-08 DOI: 10.1136/bmjinnov-2021-000921
B. Fan, Chuang Kiat Desmond Soh, Hee Chuan Darryl Heng, Lee Long Eddie Woo, W. H. Bin
Department of Haematology, Tan Tock Seng Hospital, Singapore Department of Laboratory Medicine, Khoo Teck Puat Hospital, Singapore Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore Yong Loo Lin School of Medicine, National University of Singapore, Singapore Medulla Pro Technology Pte Ltd, Trendlines Medical Singapore, Singapore Department of Anaesthesia, Khoo Teck Puat Hospital, Singapore
新加坡李光前医学院、南洋理工大学、新加坡永禄林医学院、新加坡国立大学、新加坡Medulla Pro Technology Pte Ltd .、新加坡Trendlines Medical Singapore、新加坡Khoo Teck Puat医院麻醉科
{"title":"Development of a real time ultrasound guided lumbar puncture device","authors":"B. Fan, Chuang Kiat Desmond Soh, Hee Chuan Darryl Heng, Lee Long Eddie Woo, W. H. Bin","doi":"10.1136/bmjinnov-2021-000921","DOIUrl":"https://doi.org/10.1136/bmjinnov-2021-000921","url":null,"abstract":"Department of Haematology, Tan Tock Seng Hospital, Singapore Department of Laboratory Medicine, Khoo Teck Puat Hospital, Singapore Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore Yong Loo Lin School of Medicine, National University of Singapore, Singapore Medulla Pro Technology Pte Ltd, Trendlines Medical Singapore, Singapore Department of Anaesthesia, Khoo Teck Puat Hospital, Singapore","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":"21 1","pages":"307 - 311"},"PeriodicalIF":2.0,"publicationDate":"2022-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89267513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Building the social innovation for health ecosystem in Latin America: experiences and learning from SIHI-LAC 建立拉丁美洲卫生生态系统的社会创新:从拉美和加勒比地区的经验和学习
IF 2 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2022-06-08 DOI: 10.1136/bmjinnov-2021-000898
L. van Niekerk, M. I. Echavarria, J. Alger, D. Castro-Arroyave, Martha Milena Bautista-Gómez, Claudia Ivette Nieto Anderson, B. Beltran, L. Cuervo
Social innovation for health has grown in relevance and momentum across Latin America.1-5 Yet, the potential of social innovation for health appears mostly untapped, with one reason for this being the limited investment to build strong ecosystems that can support social innovation initiatives.6-8
在整个拉丁美洲,卫生社会创新的相关性和势头都在增强。1-5然而,卫生社会创新的潜力似乎大多未得到开发,其中一个原因是,用于建立能够支持社会创新举措的强大生态系统的投资有限
{"title":"Building the social innovation for health ecosystem in Latin America: experiences and learning from SIHI-LAC","authors":"L. van Niekerk, M. I. Echavarria, J. Alger, D. Castro-Arroyave, Martha Milena Bautista-Gómez, Claudia Ivette Nieto Anderson, B. Beltran, L. Cuervo","doi":"10.1136/bmjinnov-2021-000898","DOIUrl":"https://doi.org/10.1136/bmjinnov-2021-000898","url":null,"abstract":"Social innovation for health has grown in relevance and momentum across Latin America.1-5 Yet, the potential of social innovation for health appears mostly untapped, with one reason for this being the limited investment to build strong ecosystems that can support social innovation initiatives.6-8","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":"268 1","pages":"224 - 233"},"PeriodicalIF":2.0,"publicationDate":"2022-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77168910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Social innovation in health: concepts and practice 卫生领域的社会创新:概念与实践
IF 2 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2022-06-08 DOI: 10.1136/bmjinnov-2022-000982
Joseph D. Tucker, L. Manderson, U. Amazigo, J. Alger, Elizabeth Chen, M. Labarda, E. Kpokiri, P. Dako-Gyeke, R. Peeling, L. Cuervo, B. Halpaap
{"title":"Social innovation in health: concepts and practice","authors":"Joseph D. Tucker, L. Manderson, U. Amazigo, J. Alger, Elizabeth Chen, M. Labarda, E. Kpokiri, P. Dako-Gyeke, R. Peeling, L. Cuervo, B. Halpaap","doi":"10.1136/bmjinnov-2022-000982","DOIUrl":"https://doi.org/10.1136/bmjinnov-2022-000982","url":null,"abstract":"","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":"21 1","pages":"133 - 136"},"PeriodicalIF":2.0,"publicationDate":"2022-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87526556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Technological innovation in vascular access surgery: a reflection on two recent developments 血管通路手术的技术革新:对两项最新进展的反思
IF 2 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2022-06-07 DOI: 10.1136/bmjinnov-2021-000854
A. Williamson
© Author(s) (or their employer(s)) 2022. No commercial reuse. See rights and permissions. Published by BMJ. INTRODUCTION The discipline of vascular access surgery can be defined as the facilitation of dialysis through rapid and easy access to a patient’s bloodstream. 2 This is one of the most fundamental diagnostic and therapeutic principles in the care of renal failure patients; however, instruments to achieve this in a controlled manner were only developed midway through the 17th century. By the early 20th century, the earliest dialysis machines had been created; however, haemodialysis could not continue beyond a couple of dozen treatments per patient—there was an exhaustion of access as the blood vessels would be ligated (‘tiedoff ’) after each treatment to prevent excessive bleeding. Modern vascular access methods were born in the 1950s when the first central venous catheters (CVCs—catheter entering a central vein), arteriovenous grafts (AVG—a synthetic tube connecting an artery and a vein) and native arteriovenous fistulas (AVF—a surgically created communication between an artery and a vein) were used. Technological advancement in these early stages focused on vascular anastomosis techniques and arteriovenous shunting (directing arterial blood through the venous system) materials to overcome access failure and thrombosis, respectively. The need for innovation to overcome the shortcomings of previous technologies or practices is an ongoing process—this report describes the driving forces behind two recent developments in the field of vascular access and evaluates their advantages and disadvantages against alternate technologies and their current use in clinical practice: ► The Hemodialysis Reliable Outflow (HeRO) graft—a twocomponent graft aiming to overcome the problem of central venous stenosis (luminal narrowing of the central veins). ► Percutaneous endovascular fistula creation—imageguided fistula creation aiming to avoid complications associated with open surgically created AVFs.
©作者(或其雇主)2022。禁止商业重用。请参阅权利和权限。英国医学杂志出版。血管通路手术的学科可以被定义为通过快速和容易地进入病人的血液来促进透析。这是肾衰竭患者护理中最基本的诊断和治疗原则之一;然而,以一种可控的方式实现这一目标的仪器直到17世纪中期才被开发出来。到20世纪初,最早的透析机已经制造出来;然而,血液透析不能在每个病人进行几十次以上的治疗,因为每次治疗后血管都会被结扎(“捆扎”),以防止过度出血,因此血液透析的途径会耗尽。现代血管通路方法诞生于20世纪50年代,当时首次使用了中心静脉导管(cvc -进入中心静脉的导管)、动静脉移植物(avg -连接动脉和静脉的合成管)和原生动静脉瘘(avf -手术创建的动脉和静脉之间的通信)。这些早期阶段的技术进步分别集中在血管吻合技术和动静脉分流(通过静脉系统引导动脉血液)材料上,以克服通路失败和血栓形成。需要创新来克服以前技术或实践的缺点是一个持续的过程——本报告描述了血管通路领域两项最新发展背后的驱动力,并评估了它们相对于替代技术的优缺点及其目前在临床实践中的应用:血液透析可靠流出(HeRO)移植物-一种双组分移植物,旨在克服中心静脉狭窄(中心静脉管腔狭窄)的问题。经皮血管内造瘘术——影像引导下造瘘术旨在避免开放性手术造瘘的并发症。
{"title":"Technological innovation in vascular access surgery: a reflection on two recent developments","authors":"A. Williamson","doi":"10.1136/bmjinnov-2021-000854","DOIUrl":"https://doi.org/10.1136/bmjinnov-2021-000854","url":null,"abstract":"© Author(s) (or their employer(s)) 2022. No commercial reuse. See rights and permissions. Published by BMJ. INTRODUCTION The discipline of vascular access surgery can be defined as the facilitation of dialysis through rapid and easy access to a patient’s bloodstream. 2 This is one of the most fundamental diagnostic and therapeutic principles in the care of renal failure patients; however, instruments to achieve this in a controlled manner were only developed midway through the 17th century. By the early 20th century, the earliest dialysis machines had been created; however, haemodialysis could not continue beyond a couple of dozen treatments per patient—there was an exhaustion of access as the blood vessels would be ligated (‘tiedoff ’) after each treatment to prevent excessive bleeding. Modern vascular access methods were born in the 1950s when the first central venous catheters (CVCs—catheter entering a central vein), arteriovenous grafts (AVG—a synthetic tube connecting an artery and a vein) and native arteriovenous fistulas (AVF—a surgically created communication between an artery and a vein) were used. Technological advancement in these early stages focused on vascular anastomosis techniques and arteriovenous shunting (directing arterial blood through the venous system) materials to overcome access failure and thrombosis, respectively. The need for innovation to overcome the shortcomings of previous technologies or practices is an ongoing process—this report describes the driving forces behind two recent developments in the field of vascular access and evaluates their advantages and disadvantages against alternate technologies and their current use in clinical practice: ► The Hemodialysis Reliable Outflow (HeRO) graft—a twocomponent graft aiming to overcome the problem of central venous stenosis (luminal narrowing of the central veins). ► Percutaneous endovascular fistula creation—imageguided fistula creation aiming to avoid complications associated with open surgically created AVFs.","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":"84 1","pages":"291 - 295"},"PeriodicalIF":2.0,"publicationDate":"2022-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75107336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Youth researchers academy: a report on an innovative research training programme for young people in Zimbabwe 青年研究人员学院:关于津巴布韦青年创新研究培训方案的报告
IF 2 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2022-06-06 DOI: 10.1136/bmjinnov-2021-000885
M. Tembo, C. Mackworth-Young, K. Kranzer, Chido Dziva-Chikwari, C. Mavodza, E. Dauya, Mufaro Makuni, Dakarai Chipare, Blessing Munyavi-Dehwe, Daniel Raradza, S. Bernays, R. Chingono, N. Dzavakwa, Rudo Nyamwanza, S. Francis, V. Simms, R. Ferrand
Introduction Youth engagement has the potential to enhance the design, implementation and relevance of research. Without strategies to capacitate young people with research skills, youth engagement in research is often tokenistic and ineffective. In this paper, we detail the implementation and evaluation of an innovative research training programme for youth (aged 18–24 years) in Zimbabwe called the Youth Researchers Academy (YRA). Methods Quantitative programme data and qualitative interviews and focus group discussions assessed acceptability of the YRA, youth researcher and mentor experiences, and impact of the YRA over time. Results We received 60 applications in 2019 and 89 applications in 2021. Ongoing feedback led to changes in the second programme (including longer training and certification). Youth researcher experiences included being motivated by learning new skills and valuing the relationship with mentors and peer networks. Many described long-term impact, including facilitation of higher education, setting up of new businesses through the stipends received, and, for some, opportunities to work in research. Discussion Overall, the programme was acceptable, facilitated meaningful youth-led research and trained a cohort of empowered youth researchers. Young people were eager to learn and capable of both learning and implementing critical research skills in a professional working environment. Implementation challenges included limited freedom in the co-design of research projects and the additional burden of work for YRA mentors. Conclusion The YRA provides a template for other academics to support similar training to facilitate capacity building and meaningful youth engagement for research with and for youth.
青年参与有可能提高研究的设计、实施和相关性。如果没有使年轻人具备研究技能的战略,青年参与研究往往是象征性的和无效的。在本文中,我们详细介绍了津巴布韦青年(18-24岁)创新研究培训计划的实施和评估,该计划被称为青年研究学院(YRA)。方法定量项目数据、定性访谈和焦点小组讨论,评估青年研究员和导师的经验,青年研究员和导师的可接受性,以及随着时间的推移,青年研究员和导师的影响。结果2019年收到60份申请,2021年收到89份申请。持续不断的反馈导致第二个方案的变化(包括较长的培训和证书)。青年研究员的经历包括被学习新技能所激励,重视与导师和同伴网络的关系。许多人描述了长期影响,包括促进高等教育,通过收到的津贴建立新企业,以及一些人从事研究工作的机会。总的来说,该方案是可以接受的,促进了有意义的青年领导的研究,并培训了一批有能力的青年研究人员。年轻人渴望学习,并且有能力在专业的工作环境中学习和实施关键的研究技能。实施方面的挑战包括共同设计研究项目的有限自由,以及YRA导师的额外工作负担。YRA为其他学术机构提供了一个模板,以支持类似的培训,促进能力建设和有意义的青年参与与青年合作和为青年服务的研究。
{"title":"Youth researchers academy: a report on an innovative research training programme for young people in Zimbabwe","authors":"M. Tembo, C. Mackworth-Young, K. Kranzer, Chido Dziva-Chikwari, C. Mavodza, E. Dauya, Mufaro Makuni, Dakarai Chipare, Blessing Munyavi-Dehwe, Daniel Raradza, S. Bernays, R. Chingono, N. Dzavakwa, Rudo Nyamwanza, S. Francis, V. Simms, R. Ferrand","doi":"10.1136/bmjinnov-2021-000885","DOIUrl":"https://doi.org/10.1136/bmjinnov-2021-000885","url":null,"abstract":"Introduction Youth engagement has the potential to enhance the design, implementation and relevance of research. Without strategies to capacitate young people with research skills, youth engagement in research is often tokenistic and ineffective. In this paper, we detail the implementation and evaluation of an innovative research training programme for youth (aged 18–24 years) in Zimbabwe called the Youth Researchers Academy (YRA). Methods Quantitative programme data and qualitative interviews and focus group discussions assessed acceptability of the YRA, youth researcher and mentor experiences, and impact of the YRA over time. Results We received 60 applications in 2019 and 89 applications in 2021. Ongoing feedback led to changes in the second programme (including longer training and certification). Youth researcher experiences included being motivated by learning new skills and valuing the relationship with mentors and peer networks. Many described long-term impact, including facilitation of higher education, setting up of new businesses through the stipends received, and, for some, opportunities to work in research. Discussion Overall, the programme was acceptable, facilitated meaningful youth-led research and trained a cohort of empowered youth researchers. Young people were eager to learn and capable of both learning and implementing critical research skills in a professional working environment. Implementation challenges included limited freedom in the co-design of research projects and the additional burden of work for YRA mentors. Conclusion The YRA provides a template for other academics to support similar training to facilitate capacity building and meaningful youth engagement for research with and for youth.","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":"22 1","pages":"183 - 189"},"PeriodicalIF":2.0,"publicationDate":"2022-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91006762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
期刊
BMJ Innovations
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1